Sponsor

BioInvent International AB

Clinical research sponsor

Published trials3
Recruiting shown0
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

3 shown
BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid TumorsNCT06205706 · lead sponsor · 2023-12-04
ACTIVE_NOT_RECRUITING
BI-1607 in Combination with Trastuzumab in Subjects with HER2-positive Advanced Solid TumorsNCT05555251 · lead sponsor · 2022-07-28
TERMINATED
A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid TumorsNCT04725331 · collaborator · 2021-02-25
TERMINATED

Sponsor roles

lead sponsor2
collaborator1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.